OuroBoros Inc., a San Diego-based developer of treatments for spinal disorders, has secured $1.17 million of a $4 million Series A round, according to a regulatory filing. Ascent Biomedical Ventures led the deal. www.abvlp.com
OuroBoros Inc., a San Diego-based developer of treatments for spinal disorders, has secured $1.17 million of a $4 million Series A round, according to a regulatory filing. Ascent Biomedical Ventures led the deal. www.abvlp.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.